Resident Doctor Neuro Rehabilitation
About the job
- GMC registration and a licence to practise in the United Kingdom.
- Completion of Foundation training and at least IMT-2/Core Medical Training or equivalent.
- At least 1–2 years of experience in neurology, stroke medicine, or rehabilitation medicine.
- Full Membership of the Royal Colleges of Physicians (MRCP).
- Provide day-to-day inpatient medical management, including clerking admissions, daily ward rounds, and routine clinical reviews.
- Support continuity of care across inpatient and outpatient pathways.
- Collaborate closely with internationally recognised consultants, specialist therapists, and nurses.
Resident Doctor – Neuro Rehabilitation Ward
Location: London, The Wellington Hospital, St John’s Wood.
Contract: Permanent, Part-Time (30 hours per week) Will include Days/Nights and Weekend on rota.
Salary: Circa £70000-75000 FTE per annum, depending on experience.
Benefits: Private Medical Healthcare Insurance, paid indemnity, private pension, paid study leave, investment of education or research, plus more below.
Join the UK’s largest independent neurological rehabilitation private patient unit and make a real difference.
We are seeking Registrar-level doctors with a background in Acute Medicine and a special interest or experience in Neurology or Stroke Rehabilitation Medicine to join our world-class team at The Wellington Hospital. You’ll work alongside leading consultants and an exceptional multidisciplinary team to care for patients, offering comprehensive inpatient programmes for adults with acquired brain injury, neurological conditions, and complex medical disabilities. 54 beds across three floors. State-of-the-art gym and hydrotherapy pool. Cutting-edge technology, including robotics and advanced therapies
This is a unique opportunity to work in an environment at the forefront of clinical innovation, with exceptional patient-to-staff ratios that allow you to deliver truly personalised care. All in a world-class environment, equipped with the very latest technology, such as robotics, and some of the most advanced therapies and treatments currently licenced in the UK. And, with exceptionally strong colleague to patient ratios, you’ll have all the time you need to provide truly bespoke care to your patients.
While we are a Consultant Led Service, we believe in empowering our Resident Doctors, so your role could become expand as much as you wish. You’ll have the chance to be involved in audits, projects and quality improvement initiatives alongside the opportunity to join a variety of internal networks. This could be to help steer the services you deliver, speaking up or patient satisfaction focus groups, clinical governance or MDT meetings. Giving you an opportunity to network with your peers, share best practice and expand your knowledge in an unrivalled setting.
What you will do:
Provide day-to-day inpatient medical management, including clerking admissions, daily ward rounds, and routine clinical reviews
Support continuity of care across inpatient and outpatient pathways
Collaborate closely with internationally recognised consultants, specialist therapists, and nurses
What You’ll Bring:
GMC registration and licence to practise in the UK
Completion of Foundation training and at least IMT-2/Core Medical Training (or equivalent)
Minimum 1–2 years’ experience in neurology, stroke medicine, or rehabilitation medicine
Full MRCP
A passion for teamwork and delivering exceptional patient care
Why HCA UK?
Originally founded over 50 years ago by Dr Thomas Frist, HCA has gone on to become one of the world’s leading healthcare providers. In the UK, we’re one of the largest providers of privately funded healthcare and have invested over £500 million in the latest treatments, technology, techniques, medication and facilities. Being part of a large multisite, established healthcare group we can offer you unrivalled opportunities for career progression through internal and external courses, as well as working conditions that prioritise both your mental and physical wellbeing.
We believe that by caring for our employees, we empower them to provide exceptional care for our patients. That’s why we offer a host of flexible benefits that reflect the invaluable contribution they make every day. As a Resident Doctor Neuro Rehab you’ll be eligible for:
For 40 hours full time contracts, 264 hours holiday each year (inclusive of bank holidays) increasing with service, with option to buy or sell leave to suit you. This is pro-rata for part time contracts.
Private Healthcare Insurance for treatment at our leading hospitals Private pension contribution which increases with length of service
Season Ticket Loan and Cycle to Work scheme
Group Life Assurance from day one
Critical illness cover
Enhanced Maternity and Paternity pay
Corporate staff discount for all facilities including Maternity packages at The Portland
Comprehensive range of flexible health, protection and lifestyle benefits to suit you
Discounts with over 800 major retailers
Access to wellbeing support tools, through our thrive 365 channels, onsite mental health first aiders, and free counselling up to 6 sessions per annum
Paid Indemnity
How we can support your development:
As Doctor with us you’ll have access to a dedicated study budget and study leave for courses relevant to your specialty
We can also offer you access to a comprehensive learning academy where you can enrol on courses or Harvard Business Course case review forums
If you’d like to develop further, we’re able to offer grants and sponsorship for research, as well as funding for personal development through courses such as the ‘Executive Masters in Medical Leadership’ in partnership with Bayes Business School, or other courses such as MBA’s or PhDs
Should you wish, you can also work closely with globally recognised professors and medical mentors to help produce publications papers or research documents
Culture and values:
At HCA UK we believe exceptional care starts with our people. We celebrate the unique perspectives and different experiences each of us bring as we know that when you feel seen, heard and supported you can be at your best for our patients, and each other.
Our mission is simple, above all else we’re committed to the care and improvement of human life, a clear statement that extends to both our patients and colleagues. To achieve this, we live and breathe four core values:
Unique and Individual: We recognise and value everyone as unique and individual
Kindness and compassion: We treat people with kindness and compassion
Honesty, integrity and fairness: - We act with absolute honesty, integrity and fairness
Loyalty, respect and dignity: We trust and treat one another as valued members of the HCA UK family with loyalty, respect and dignity
Reasonable adjustments:
We believe everyone should feel comfortable to bring their full self to work and be afforded the same opportunities. As a Disability Confident committed organisation, we’re happy to discuss flexible working arrangements to suit your needs as well as offer reasonable adjustments throughout our recruitment process, and in the workplace, to anyone that needs them.
#LI-RG2
About the company
HCA Healthcare UK operates a large network of healthcare facilities, including hospitals and 2,600 care sites across the UK and beyond, delivering medical services through its staff and facilities. Its care is organized through a data-driven learning health system that analyzes around 47 million annual patient encounters to improve treatments and outcomes. The company stands out because of its scale, breadth of services, and its 320,000 colleagues who focus on patient care, combined with using experiences from patients to advance science and transform care. Its goal is to create a healthier tomorrow by improving patient care, advancing medical knowledge, and supporting communities through employment, investment, and charitable giving.
Company Size
10,001+
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
1968
Get referred to HCA Healthcare UK
See people who can refer or advise you
Simplify's Take
What believers are saying
- St Paul's Outpatients opens in early 2027, adding £17 million of City demand.
- Canary Wharf and Wimpole Street capacity increases on June 2, 2026 deepen referral capture.
- The VivaScore partnership extends screening engagement for twelve months after each patient visit.
What critics are saying
- The September 9, 2026 Branson inquest tied Lister failures to a preventable death.
- CMA scrutiny over central London pricing still hangs over HCA UK expansion decisions.
- A major adverse event at The Harley Street Clinic could damage trust in premium cancer care.
What makes HCA Healthcare UK unique
- HCA UK launched its first global MR-Linac at The Harley Street Clinic on September 15, 2026.
- HCA UK runs over 30 facilities, with 3,000+ specialists and 8,500 UK employees.
- HCA UK holds more CQC Outstanding locations than any UK private hospital network.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Paid Holidays
- Commuter Benefits
- Life Insurance
- Parental Leave
- Employee Discounts
- Professional Development Budget
Company News
HCA Healthcare UK invests £15 million to advance MR-guided radiotherapy. * September 15, 2026 HCA Healthcare UK (HCA UK) has expanded its radiotherapy capabilities with the introduction of the Elekta Unity MR-Linac at The Harley Street Clinic, bringing highly personalised radiotherapy treatment to patients and furthering its complex cancer care offering. The MR-Linac combines a high-resolution MRI scanner with a linear accelerator, enabling clinicians to visualise tumours in real time while delivering radiotherapy. This approach, known as MR-guided and adaptive radiotherapy, allows treatment to be precisely targeted, even as tumours move or change shape during a treatment session. The technology is particularly beneficial for cancers in areas of the body that are subject to movement during a treatment, such as prostate and central lung tumours. By continuously tracking tumour motion and adapting treatment accordingly, clinicians can deliver higher radiation doses with increased accuracy. This may reduce the number of treatment sessions required for some patients while protecting surrounding healthy tissue. The acquisition of this state-of-the-art image-guided radiotherapy represents a significant investment of £15 million for HCA UK and marks the organisation's first MR-Linac system globally. The Harley Street Clinic becomes one of only a small number of providers in London to offer this advanced form of radiotherapy. Treatment will be delivered by HCA UK's multidisciplinary cancer team, including consultant clinical oncologists, physicists, dosimetrists and radiographers, who work together on treatment planning and delivery. The service will be led by dedicated MR-Linac consultant, Dr Elena Moreno Olmedo, an expert in MR-guided radiotherapy. Dr Moreno Olmedo will oversee treatment sessions, working closely with the wider team to adapt each patient's radiotherapy plan in real time to ensure optimal precision. The introduction of the technology coincides with HCA UK joining the international Elekta MR-Linac Consortium, a global collaboration of leading centres focused on advancing evidence-based use of MR-guided radiotherapy. The consortium aims to optimise treatment approaches, improve tumour control and survival outcomes, and enhance patient quality of life through ongoing research and shared clinical expertise. This latest addition further strengthens HCA UK's commitment to offering innovative cancer treatments and expanding access to cutting-edge technologies for patients in the UK. Dr John Conibear, Clinical Oncologist and Radiotherapy Lead Clinician at HCA UK, said: "MR-guided radiotherapy represents a significant advancement in how we deliver precision cancer treatment. The ability to see and respond to tumour motion in real time allows us to treat with greater accuracy and confidence, particularly for tumours that have traditionally been challenging to target. Ultimately, this means we can deliver highly personalised care with the potential for improved outcomes and fewer treatment sessions for patients." William Pressley, CEO at The Harley Street Clinic, said: "We're proud to be one of the first independent hospitals in London to offer advanced radiotherapy with the use of the MR-Linac at The Harley Street Clinic. The introduction of this technology reflects our continued investment in advanced cancer care and our commitment to providing patients with access to the latest treatment innovations. This technology enables our expert teams to deliver highly precise, adaptive radiotherapy, reinforcing our position as a leading centre for complex cancer treatment."
HCA expands radiotherapy capabilities with MR Linac launch. HCA Healthcare UK (HCA UK) has expanded its radiotherapy capabilities with the introduction of the Elekta Unity MR-Linac at The Harley Street Clinic, bringing personalised radiotherapy treatment to patients and furthering its complex cancer care offering. The MR-Linac combines a high-resolution MRI scanner with a linear accelerator, enabling clinicians to visualise tumours in real time while delivering radiotherapy. This approach, known as MR-guided and adaptive radiotherapy, allows treatment to be precisely targeted, even as tumours move or change shape during a treatment session. HCA explains the technology is particularly beneficial for cancers in areas of the body that are subject to movement during a treatment, such as prostate and central lung tumours. By continuously tracking tumour motion and adapting treatment accordingly, clinicians can deliver higher radiation doses with increased accuracy, HCA said, adding this may reduce the number of treatment sessions required for some patients while protecting surrounding healthy tissue. This acquisition of this image-guided radiotherapy represents a significant investment of £15m for HCA UK and marks the organisation's first MR-Linac system globally. The Harley Street Clinic becomes one of only a small number of providers in London to offer this advanced form of radiotherapy. Treatment will be delivered by HCA UK's multi-disciplinary cancer team, including consultant clinical oncologists, physicists, dosimetrists and radiographers, who work together on treatment planning and delivery. The service will be led by dedicated MR-Linac consultant, Dr Elena Moreno Olmedo, an expert in MR-guided radiotherapy. Dr Moreno Olmedo will oversee treatment sessions, working closely with the wider team to adapt each patient's radiotherapy plan in real time to ensure optimal precision. The introduction of the technology coincides with HCA UK joining the international Elekta MR-Linac Consortium, a global collaboration of centres focused on advancing evidence-based use of MR-guided radiotherapy. The consortium aims to optimise treatment approaches, improve tumour control and survival outcomes, and enhance patient quality of life through ongoing research and shared clinical expertise. Dr John Conibear, clinical oncologist and radiotherapy lead clinician at HCA UK, said: "MR-guided radiotherapy represents a significant advancement in how Healthcare & Protection deliver precision cancer treatment. "The ability to see and respond to tumour motion in real time allows Healthcare & Protection to treat with greater accuracy and confidence, particularly for tumours that have traditionally been challenging to target. "Ultimately, this means we can deliver highly personalised care with the potential for improved outcomes and fewer treatment sessions for patients." William Pressley, CEO at The Harley Street Clinic, added: "Healthcare & Protection is proud to be one of the first independent hospitals in London to offer advanced radiotherapy with the use of the MR-Linac at The Harley Street Clinic. "The introduction of this technology reflects its continued investment in advanced cancer care and its commitment to providing patients with access to the latest treatment innovations. "This technology enables our expert teams to deliver highly precise, adaptive radiotherapy, reinforcing our position as a leading centre for complex cancer treatment."
VivaScore partners with HCA Healthcare UK to extend the impact of health screening through cutting-edge digital platform. VivaScore has announced a new partnership with HCA Healthcare UK to help patients stay engaged with their health between screening appointments. LONDON, UNITED KINGDOM, July 1, 2026 /EINPresswire.com/ - VivaScore has announced a new partnership with HCA Healthcare UK to support patients in staying engaged with their health between health screens, using its digital platform to provide accessible, data-driven insights outside of the clinical setting. The collaboration brings VivaScore's technology together with HCA Healthcare UK's doctor-led health screening services, creating a more connected experience that helps individuals stay focused on their health beyond the clinic. HCA Healthcare UK's screening programmes are designed to identify clinically significant risks through comprehensive testing, including cardiovascular health, cancer markers and genetic risk factors. GP-led with access to advanced diagnostics, each screen provides patients with a clear understanding of their health and recommended next steps. As part of the partnership, patients attending an HCA Healthcare UK health screen will receive 12 months' complimentary access to VivaScore. The platform enables individuals to complete remote digital health check-ins using a smartphone, generating data-led insights that help them stay connected to their health year-round. VivaScore's technology enhances the post-screening experience by enabling: · Ongoing engagement with key health indicators · Greater awareness of potential changes between screening appointments · Data-driven insights to support lifestyle and wellbeing decisions · A simple, intuitive digital experience that fits into everyday life By introducing an accessible digital layer alongside clinical screening, the partnership helps individuals maintain momentum after their appointment, reinforcing positive behaviour change and supporting a more consistent approach to prevention. Simon Spurr, CEO of VivaScore, said: "Health screening offers a powerful snapshot of an individual's health at a point in time. At VivaScore, we're focused on what happens next. Our technology makes it easy for people to stay connected to their health in a simple, everyday way, helping them build better awareness and habits between appointments." Dr Niaz Khan, Chief Clinical Officer at HCA Healthcare UK Primary Care, said: "Our health screening programmes are designed to identify risks at the earliest opportunity, supported by direct access to advanced diagnostics and specialist care. Through our partnership with VivaScore, we are extending that support beyond the clinical setting, enabling patients to remain more connected to and -actively engaged with their health. This collaboration reflects our continued focus on innovation and on delivering meaningful, long-term value to patients, while ensuring everything we offer remains firmly aligned to our clinical standards and the integrity of our screening pathways." As healthcare continues to evolve, the partnership reflects a growing focus on combining clinical expertise with accessible digital tools to help individuals stay engaged with their health beyond traditional points of care. About VivaScore VivaScore is a global health technology company leveraging artificial intelligence to transform how individuals understand and manage their health. Its platform delivers predictive insights, personalised scoring, and actionable recommendations to improve long-term wellbeing. About HCA Healthcare UK HCA Healthcare UK is one of the UK's leading private healthcare providers, offering a full range of medical services including GP care, diagnostics and advanced health screening. Its doctor-led screening programmes combine clinical expertise with advanced diagnostics to provide patients with clear, personalised health insights and access to specialist care where needed. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. Healthcare Industry Today do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
HCA Healthcare UK invests in new £17m medical centre. HCA Healthcare UK is expanding its network, with a new 17 million GBP outpatient, primary care and diagnostics centre located directly next to St Paul's Cathedral and the London Stock Exchange. Opening in early 2027, St Paul's Outpatients will offer City workers and residents' fast access to private GP appointments, health screening, specialist care, and advanced diagnostics - all in one central location. The new centre is located at Paternoster Square, serving more than 680,000 workers who are estimated to work in the area. It is designed to meet the rising demand for workplace health services, with a focus on prevention, early detection, and fast access to medical care. The facility will provide GP-led primary care, comprehensive health screening, and specialist consultations across 18 consulting rooms alongside a comprehensive range of on-site diagnostics including two MRIs, ultrasound, X-ray and mammography. Patients and employers will benefit from a variety of 'one-stop' clinics, rapid access to diagnostics and seamless referral pathways to HCA UK's wider network where onward care is required. This investment forms part of HCA UK's continued growth across London, following the opening of Canary Wharf Outpatients in 2024 and recent expansions including the Women's Health Centre - Kings Road and Women's Health Centre - Harley Street. It will build on the success of The Shard Outpatients - approaching its 10-year anniversary in 2026 - which plays an important role in delivering healthcare services to the City's workforce. St Paul's Outpatients will be operated by London Bridge Hospital, with specialist consultants joining from across HCA UK's network, including London Bridge Hospital, Princess Grace Hospital and The Harley Street Clinic. The centre will range in a wide variety of specialties, with expertise including women's health, orthopaedics, cardiac services, and cancer care. Soraya Chamberlain, Vice President of Corporate Sales at HCA Healthcare UK said: "With the opening of HCA Healthcare UK's St Paul's Outpatients in early 2027, we are strengthening the support we provide to employers and employees across the City. This new centre will offer convenient access to GP appointments, health screening, diagnostics and specialist care - all in one location - informed by the needs and insights gained through working with many of these businesses." John Reay, President and CEO of HCA Healthcare UK said: "Our £17m investment is part of our ongoing commitment to investing in our network to provide convenient access points of care for patients across London. From primary care and health screening through to specialist diagnostics and treatment, this new centre will further enhance the breadth and reach of the high-quality care we provide across the capital."
Additionally, in July 2024, Medtronic introduced the Live Stream function for its Touch Surgery digital technology ecosystem, incorporating AI-powered capabilities.